Efthymios N. Deliargyris

Showing 1-4 of 4 articles

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

Vaduganathan M, Harrington R, Stone G, Steg P, Gibson M, Hamm C, Price M, Lopes R, Leonardi S, Deliargyris E, Prats J, Mahaffey K, White H, Bhatt D

February 2, 2018 | 10.4244/EIJ-D-17-00723

Coronary interventions

Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study

van Geuns R, Sideris G, van Royen N, El Mahmoud R, Diletti R, Sollier C, Garot J, Van Der Hoeven N, Cortese B, Ding L, Lechthaler I, Deliargyris E, Anthopoulos P, Drouet L

August 4, 2017 | 10.4244/EIJ-D-17-00307

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

Geisler T, Müller K, Karathanos A, Bocksch W, Gawaz M, Deliargyris E, Bernstein D, Lincoff A, Mehran R, Dangas G, Stone G

May 20, 2014 | 10.4244/EIJV10I1A16

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao S, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

August 24, 2012 | 10.4244/EIJV8I4A76

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

Guidance Papers

Guidelines, consensus & position papers

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Coronary Artery Thrombosis, Maveric Trial...

Valvular disease